SCHEMBL19662804

SCHEMBL19662804

Cc1cccc(C(=O)Nc2cnn(C)c2)c1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 6/20 0.65
EGFR P00533 2/20 0.62
FGFR1 P11362 2/20 0.62
KDR P35968 2/20 0.62
KCNK3 O14649 3/20 0.61
KCNK9 Q9NPC2 3/20 0.61
KCNH2 Q12809 1/20 0.61
NT5E P21589 1/20 0.59
NPC1 O15118 4/20 0.58
RAB9A P51151 4/20 0.58
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
RXFP1 Q9HBX9 1/20 0.57
TAS2R8 Q9NYW2 1/20 0.57
POLB P06746 1/20 0.57
TP53 P04637 1/20 0.57
MAPK8 P45983 1/20 0.54
MAPK10 P53779 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19662799 0.85 KDM1A (0.63) KDM1AEGFRFGFR1KDRNPC1
SCHEMBL16976932 0.85 EGFR (0.67) KDM1AEGFRFGFR1KDRKCNK3
SCHEMBL6966254 0.84 EGFR (0.70) KDM1AEGFRFGFR1KDRNPC1
SCHEMBL24934054 0.83 DHX9 (0.69) EGFRFGFR1KDRKCNK3KCNK9
SCHEMBL21237224 0.83 KDM1A (0.61) KDM1AEGFRFGFR1KDRNPC1
SCHEMBL21237370 0.83 EGFR (0.61) KDM1AEGFRFGFR1KDRMAPK8
SCHEMBL28692735 0.79 LMNA (0.63) KDM1AEGFRFGFR1KDRKCNK3
SCHEMBL17003226 0.79 KDM1A (1.00) KDM1A
SCHEMBL16482524 0.79 KDM1A (1.00) KDM1A
SCHEMBL16675166 0.78 KCNK3 (0.89) KCNK3KCNK9KCNH2NT5ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017205538-A1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH, INC. (US) 2017-11-30 WO disclosed